Announcement on Voluntary Disclosure of Obtaining Notice of Drug Clinical Trial Approval for New Indications of Furmonertinib

About this update from Shanghai Allist Pharmaceuticals Co. Ltd. Class A

Announcement on Voluntary Disclosure of Obtaining Notice of Drug Clinical Trial Approval for New Indications of FurmonertinibThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shanghai Allist Pharmaceuticals Co. Ltd. Class A